Clinical Trial Detail

NCT ID NCT03025256
Title Study of Concurrent Intravenous and Intrathecal Nivolumab for Patients With Leptomeningeal Disease (LMD)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

melanoma

Therapies

Nivolumab

Age Groups: adult senior

No variant requirements are available.